Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Ronald C. Desrosiers is interviewed about the possibility of using a live-attenuated HIV vaccine in human trials. Desrosiers describes the processes that were used to develop a vaccine for SIV and talks about moving the trials from monkeys to humans. He proposes that terminally ill patients be allowed to receive the vaccine, since data from these patients could speed up the possibility of trials with healthy humans.

Original languageEnglish (US)
Pages (from-to)22-23
Number of pages2
JournalJournal of the International Association of Physicians in AIDS Care
Volume4
Issue number11
StatePublished - Nov 1998
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary.'. Together they form a unique fingerprint.

  • Cite this